Speaker Profile

Ph.D., CEO, PolygenRx

Biography
Murray is dedicated to developing precision medicine for common chronic disorders. He has turned this passion into a business opportunity by cofounding the pharmaceutical startup PolygenRx. He is director of the Centre for Complex Disorders and Precision Medicine and Professor of Genetics at the University of Newcastle’s College of Health, Medicine and Wellbeing, School of Biomedical Sciences and Pharmacy. He is also chair of the Hunter Medical Research Institute’s Precision Medicine program. This follows many years in the pharmaceutical and biotechnology industry, including an 8-year role as senior scientist with Johnson and Johnson, which led to a significant commercial development of intellectual property captured in a family of patents. With expertise in bioinformatics, systems biology and high-throughput genomics, Murray has established an internationally recognised research program specialising in complex trait genomics and precision medicine.


Genomic Profiling Showcase:
PolygenRx

PolygenRx is a startup pharmaceutical company using genetics to improve drug discovery and function through precision medicine. Our platform improves drug performance in common disorders by matching them specifically to each patient’s biological variation.

A platform for precision medicine in common disorders
Introducing a precision medicine platform for chronic disorders that matches drugs with their heterogeneous common variant architecture.

 Session Abstract – PMWC 2022 Silicon Valley

Track 7, June 28-30


The PMWC 2022 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.